James P. Bennett, Jr. M.D., Ph.D.

James P. Bennett, Jr. is a native of St. Petersburg, FL. He received a B.S. in Chemistry (with Honors) from the University of Florida (1970), then attended Johns Hopkins University School of Medicine for his M.D. (1974) and Ph.D. (Pharmacology, 1977) degrees. He worked in the laboratory of Solomon Snyder, M.D. for six years while in medical and graduate schools and trained in neuropharmacology. He then trained clinically for two years in Internal Medicine (1978-80), followed by Neurology residency at the University of Virginia (UVa, 1980-83) where he was Chief Resident (1982-83). He became a faculty member in the UVa departments of Neurology, Psychiatry and Pharmacology (1983-2009) and held the Ebbert Chair in Medical Science. In 2009 he moved to Virginia Commonwealth University, where he held the Bemiss Chair, was Chairman of Neurology (2009-2013) and was founding Director of the Parkinson’s Disease and Movement Disorder Center (2009-2015). Dr. Bennett has held multiple NIH grants and directed the NIH-funded Udall Parkinson’s Center at UVa that was operative for 10 years. He investigates mitochondrial dysfunction in adult neurodegenerative diseases. He holds multiple patents related to experimental therapies of degenerative disorders. In June, 2015 he retired from academic medicine, moved back to Charlottesville and founded Neurodegeneration Therapeutics, Inc. (NTI). NTI has received 501(c)3 status and is a non-profit biomedical research foundation using modern stem cell and next-generation RNA sequencing technologies to develop novel “personalized” treatment of degenerative brain diseases.